App DB | Sorbent Technologies, Inc.
Home
sorbtech.com
Back
Contact an Account Manager
Reversed phase LC assay of FLA 908 a metabolite of remoxipride in hydrolyzed urine by means of a peak compression effect
Summary
Type:
HPLC
Application #:
104411
Catalog#:
720141.40 - MN HPLC Column, Nucleosil C18, 100A, 5um, 4x100mm
Detection:
UV, 214nm
Conditions:
eluent: 23% acetonitrile in phosphate buffer pH 2 with 0.4mM N,N-dimethyl-N-octylamine
flow rate 1ml/min
Authors:
Nilsson LB
Source:
Chromatographia 22 (1986) 283 - 286
Details
Legend: Fig. 2 from 1st paper. Human plasma chromatogram 6h after a 100mg oral dose of remoxipride (R), 2.49µM, I.S. internal standard, 4µM.
©2020 Copyright, All Rights Reserved, Sorbent Technologies, Inc.